Avalon Trust’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-200
Closed -$17.3K 477
2026
Q1
$17.3K Hold
200
﹤0.01% 378
2025
Q4
$19.2K Sell
200
-20
-9% -$1.94K ﹤0.01% 356
2025
Q3
$21K Buy
220
+20
+10% +$1.84K ﹤0.01% 390
2025
Q2
$17.4K Hold
200
﹤0.01% 327
2025
Q1
$18K Hold
200
﹤0.01% 335
2024
Q4
$16K Hold
200
﹤0.01% 301
2024
Q3
$18K Hold
200
﹤0.01% 268
2024
Q2
$15.7K Hold
200
﹤0.01% 272
2024
Q1
$17.4K Hold
200
﹤0.01% 278
2023
Q4
$16.5K Hold
200
﹤0.01% 280
2023
Q3
$15.7K Sell
200
-200
-50% -$16.7K ﹤0.01% 242
2023
Q2
$35.2K Hold
400
﹤0.01% 221
2023
Q1
$32.2K Buy
+400
New +$32.6K ﹤0.01% 221

Other funds holding MDT

Avalon Trust's MDT Position: Q2 2026 in Review

Avalon Trust sold out of Medtronic (MDT) in Q2 2026, closing a stake of 200 shares — an estimated $17.3K sold.

Avalon Trust first reported a position in MDT in Q1 2023 and held it in 13 quarters. The position peaked at $35.2K in Q2 2023. 2,135 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Avalon Trust reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
  • Avalon Trust sold 200 Medtronic shares in Q2 2026, an estimated $17.3K.
  • Avalon Trust first reported a position in Medtronic in Q1 2023 and held it in 13 quarters.
  • Avalon Trust's Medtronic position peaked at $35.2K in Q2 2023.
  • 2,135 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Avalon Trust's 13F filing for Q2 2026, filed 6 Aug 2026.